Ivermectin & Generics: Will Patent Cliff Fuel Off-Label Use?
The U.S. pharmaceutical industry is bracing for one of the most influential shifts of 2025: ivermectin’s patent cliff. As this long-debated antiparasitic drug enters the generic realm, a whirlwind of regulatory, economic, and public health changes is expected. But among these changes, one question stands out: Will generic ivermectin’s wider availability lead to an increase...
0 Kommentare 0 Anteile 36 Ansichten 0 Vorschau
Gesponsert

Trade with the best

aking Exness the first name that comes to mind when people think about brokers or trading. We’re putting our traders first, not only with trading conditions, but also with the overall...